251. Urea cycle disorder Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 54 / Drugs : 61 - (DrugBank : 15) / Drug target genes : 3 - Drug target pathways : 28
| Other names | - | ||
|---|---|---|---|
| Disease group | Metabolic diseases | ||
| Related info (in Japanese) | - | ||
| Designated intractable diseases (in Japanese) | Overview, Diagnostic criteria, etc. (docx), Clinical research form (pdf) | ||
| Specific pediatric chronic diseases, Japan (in Japanese) | 8-1-13. Ornitine transcarbamylase deficiency | ||
| Subtypes | No. | Name | Specific pediatric chronic diseases, Japan (in Japanese) |
| 251-1. | N-acetylglutamate synthase deficiency;NAGS deficiency; | 8-1-11. N-acetylglutamate synthetase deficiency | |
| 251-2. | Carbamoyl phosphate synthetase I deficiency;CPS1 deficiency; | 8-1-12. Carbamoylphosphate synthetase deficiency | |
| 251-3. | Ornithine transcarbamylase deficiency;OTC deficiency; | 8-1-13. Ornitine transcarbamylase deficiency | |
| 251-4. | Classic citrullinemia;Citrullinemia type I; | 8-1-14. Argininosuccinate synthetase deficiency; Citrullinaemia type 1 | |
| 251-5. | Argininosuccinic aciduria; | 8-1-15. Argininosuccinic aciduria | |
| 251-6. | Argininemia; | 8-1-16. Hyperarginemia | |
| 251-7. | Hiperornitinemia-hiperamonemia-homocitrulinuria syndrome;HHH syndrome; | 8-1-18. Hyperornithinemia | |